Page 744 - Coronavirus Vaccine

US Astra Covid-19 vaccine trial will tell how well it works: Top scientist

A top US scientist overseeing Covid-19 vaccine trials expects a large US study to determine how effective AstraZeneca's experimental inoculation is

Inhumane sanctions of US blocked our Covid-19 vaccine purchase, Iran says

The governor of Iran's central bank said the US "inhumane sanctions" have blocked Iran's purchase of vaccines needed to tackle the Covid-19 epidemic, a report said

WEF to be held in Singapore next year instead of Davos due to Covid-19

Organisers of the annual World Economic Forum event in Davos, Switzerland, have again changed their planned venue for next year's edition, announcing it will now take place in Singapore in May

To enhance immunity, UK to combine Pfizer, Astra shots in vaccine trials

The UK is set to begin administering doses from Pfizer and German partner BioNTech SE on Tuesday, making it the first Western country to receive a vaccine

Speculations around pricing: Is Covid-19 vaccine a public or private good?

As the vaccines arrive, how are they going to be distributed? Can individuals or private parties import them freely? What will the cost be? Will the disease progress the way it has?

Canada to get up to 250,000 doses of Pfizer Covid-19 vaccine by Dec end: PM

Prime Minister Justin Trudeau said Monday Canada will get up to 250,000 doses of the vaccine developed by American drugmaker Pfizer and Germany's BioNTech before the end of December.

Bharat Biotech applies for emergency use authorisation for Covaxin

The company is conducting a 26,000 subjects phase 3 efficacy trial in India to determine the efficacy of its candidate

Serum set for deal with Centre soon; to supply vaccine at Rs 250 a dose

There is still time before SII can start supplying to the low and medium income countries through Gavi

Vaccine day in Britain; Americans await regulator's nod for vaccine

Vaccine by Pfizer and BioNTech could be in use in the US by Friday if the FDA approves emergency use

Tourism ministry urges Covid-19 insurance cover for foreign tourists

Ministry's addl director general says dept is studying insurance plans offered by Singapore, talks are on with insurers and finance ministry on modalities of providing Covid cover

Sensex, Nifty end at new all-time high for third day amid vaccine optimism

The Sensex rose 347 points, or 0.77 per cent, to end at 45,427, while the Nifty gained 97 points, or 0.73 per cent, to close at 13,356

Uttar Pradesh coronavirus update: 1,515 fresh Covid-19 cases, 20 deaths

With 1,515 fresh cases, the total number of those infected by coronavirus went up to 5,56,397 in Uttar Pradesh, while the death toll rose to 7,944 following 20 more deaths on Monday

Decoded: What emergency use authorisation of Covid vaccine means for us

After the Indian arm of US pharmaceutical giant Pfizer, the Serum Institute of India has applied to the Drugs Controller General of India (DCGI) seeking emergency use authorisation

Covid LIVE: 3rd phase trial of Bharat Biotech vaccine starts in Chennai

Coronavirus live updates: At 1,852,266, Maharashtra has the highest number of coronavirus cases, followed by Karnataka 893,006, Andhra Pradesh 871,972, Tamil Nadu 790,240, and Kerala 636,392

India weighing quick emergency review of Pfizer, AstraZeneca vaccines

Serum Institute is making AstraZeneca's Covid-19 vaccine in India and has applied for emergency use authorisation.

Weak fundamentals, high valuation: Is it time to sell IndiGo, SpiceJet?

The stock of SpiceJet, for instance, has soared 80 per cent in the past month, from a level of Rs 49.6 apiece on the BSE (on closing basis) to Rs 89.3 on December 4

India Coronavirus Dispatch: Pandemic may hurt Malaria eradication progress

61% Indians know someone who died of Covid, will vaccine revive international travel, 22 experts on how to prevent future pandemics-news relevant to India's fight against Covid-19

World Coronavirus Dispatch: Tracing scientists' efforts in a brutal year

Virus may be encouraging people to live in larger groups, Taiwan's economy is spared for now, Christmas tree sellers run into surprise costs, and other pandemic-related news across the globe

Covid-19 vaccine: Don't rush to buy all logistics stocks, say analysts

Vaccine storage and transportation being a niche segment will not benefit all logistics and transportation companies, analysts say

US says Covid-19 relief package won't offer $1,200 in direct payments

US lawmakers closed in on a Covid-19 relief bill that would provide roughly $300 in extra federal weekly unemployment benefits but not another round of $1,200 in direct payments to most Americans